Department of Internal Medicine

Medicine & Life Sciences

1. Indonesia 100%
2. HIV 27%
3. Type 2 Diabetes Mellitus 22%
4. Therapeutics 18%
5. Helicobacter pylori 18%
6. Mortality 15%
7. Elderly 15%
8. Coronavirus 14%
9. Liver Cirrhosis 13%
10. Cross-Sectional Studies 12%
11. Infections 12%
12. Cohort Studies 12%
13. Pandemics 12%
14. Helicobacter Infections 11%
15. Tuberculosis 11%
16. Serum 11%
17. Population 10%
18. Gastroesophageal Reflux 10%
19. Dyspepsia 10%
20. Liver 10%
21. Randomized Controlled Trials 9%
22. Incidence 9%
23. Hemorrhage 9%
24. Meta-Analysis 9%
25. Fibrosis 9%
26. Neoplasms 9%
27. Systematic Reviews 8%
28. Diabetes Mellitus 8%
29. Hepatocellular Carcinoma 8%
30. Non-alcoholic Fatty Liver Disease 8%
31. Colorectal Neoplasms 8%
32. Quality of Life 8%
33. Acute-On-Chronic Liver Failure 8%
34. Guidelines 8%
35. Survival 8%
36. Hepacivirus 8%
37. Hypertension 7%
38. Inflammatory Bowel Diseases 7%
39. Diarrhea 7%
40. Kidney 7%
41. Fasting 7%
42. Acute Coronary Syndrome 7%
43. General Hospitals 7%
44. Diabetic Foot 7%
45. Renal Dialysis 6%
46. Dengue 6%
47. Safety 6%
48. Placebos 6%
49. Frailty 6%
50. Pharmaceutical Preparations 6%
51. Blood Glucose 6%
52. Retrospective Studies 6%
53. Nutritional Status 6%
54. Endoscopy 6%
55. Obesity 6%
56. Inflammation 6%
57. Drug Therapy 6%
58. Confidence Intervals 6%
59. Health 6%
60. Geriatrics 6%
61. Liver Diseases 6%
62. Chronic Hepatitis B 5%
63. Genotype 5%
64. SARS Virus 5%
65. Tertiary Care Centers 5%
66. Prospective Studies 5%
67. Rheumatoid Arthritis 5%
68. Blood Pressure 5%
69. Body Mass Index 5%
70. Insulin Resistance 5%
71. Chronic Renal Insufficiency 5%
72. Endoscopic Retrograde Cholangiopancreatography 5%
73. Systemic Lupus Erythematosus 5%
74. Referral and Consultation 5%
75. Proton Pump Inhibitors 5%
76. Sensitivity and Specificity 5%
77. Databases 5%
78. Acquired Immunodeficiency Syndrome 5%
79. Odds Ratio 5%
80. Esophageal and Gastric Varices 5%
81. Stomach 5%